Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07212491) titled 'Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma- Renewal Grant Aim 2 (The SOS6C Trial)' on Sept. 30.

Study Type: Observational

Primary Sponsor: Mayo Clinic

Condition: Barrett Esophagus Esophageal Adenocarcinoma

Intervention: Other: Non-Interventional Study

Recruitment Status: Not recruiting

Date of First Enrollment: October 1, 2025

Target Sample Size: 300

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07212491

Published by HT Digital Content Services with permission from H...